Additionally, GLP-1 RAs can modulate appetite-regulating centers in the hypothalamus, such as directly activating POMC neurons [63] or inhibiting AgRP neurons by acting on GLP-1R-expressing neurons in the dorsomedial hypothalamus [61,63]
The distinction is between the weight loss branded versions (Wegovy, Zepbound, Saxenda) and the diabetes-indicated versions of the same active ingredients
The adverse effects of GLP-1RA, such as nausea, constipation, and diarrhea, are thought to be the result of the pharmacological action of GLP-1, but the mechanisms have not been fully elucidated
If you are taking insulin or sulfonylureas alongside GLP-1 therapy and experience hypoglycaemia, discuss dose adjustments with your healthcare provider